Feature | May 12, 2014

Maquet Recalls Intra-Aortic Balloon Pumps Due to Potential Failure of Power Supply

Company says recall affects 12,360 IABP units sold globally

IABP, Datascope, Maquet, FDA recall

May 12, 2014 — Datascope Corp./Maquet initiated a voluntary worldwide field correction of some of its intra-aortic balloon pumps (IABPs) due to a potential mechanical failure of the fan assembly associated with the power supply. All customers that may have an IABP affected by this field correction have been notified. The company says there are about 12,360 affected units sold globally.

The firm received 106 reports of device malfunctions, which caused one death, involving its system 98/98XT, CS100, CS100i and CS300 IABPs. The firm determined that the fan assembly for the affected IABPs could contain a misshapen retaining ring. This retaining ring could separate within the fan assembly, causing the fan to stop rotating. This could result in the power supply overheating and the IABP would shut down without any warning. This device failure would cause the balloon to stop inflating and deflating. It may result in decreased blood flow to the heart and the rest of the body, difficulty in weaning the patient from cardiopulmonary bypass, and clotting or blockage of blood vessels to the intestines, kidneys, or legs. The possible long range consequences of this include organ injury or tissue damage, possibly leading to patient death.

The recalled systems were sold under the Datascope Corp. and include system 98/98XT (part numbers: 0998-00-0446-xx, 0998-UC-0446-xx, 0998-00- 0479-xx and 0998-UC-0479-xx), CS100/CS100i (Part Numbers: 0998-00-3013-xx, 0998-UC-3013-xx, 0998-UC-0446Hxx and 0998-UC-0479Hxx) and CS300 (part numbers:0998-00-3023-xx and 0998-UC-3023-xx).

The IABP is an electromechanical system used to inflate and deflate an intra-aortic balloon to provide temporary support to the left ventricle via the principle of counter pulsation.

Between Jan. 1, 2003, and June 30, 2011, specific System 98/98XT, CS100/CS100i and CS300 IABPs were manufactured with an affected fan assembly, or may have received an affected fan assembly during an upgrade/service of the IABP in the field. The affected IABP units were distributed in the United States and worldwide (in more than 100 countries). The affected IABP's can be identified by part and serial number. Each Maquet service representative has a list of the affected serial numbers and will check each affected part during the corrective action.

The affected system 98/98XT, CS100, CS100i and CS300 IABPs involved in the field correction can be used while waiting for parts and service. Customers should adhere to the instructions for use when using an affected IABP.

The U.S. Food and Drug Administration (FDA) has classified this action as a Class 1 recall. FDA defines Class 1 recalls as, "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death." To date, there have been no reported patient injuries or deaths related to the power supply malfunction.

The corrective action associated with this recall is to provide a replacement fan assembly to all IABPs containing an affected fan assembly. A Maquet service representative will contact those facilities with affected IABP's to schedule corrective action and document this corrective action during a visit to the customer.

For additional information regarding this field correction, please contact the Technical Support Department at (800) 777-4222 and press 3 (Monday through Friday 8 a.m. – 6 p.m. EST).

For more information: www.fda.gov/MedicalDevices/NewsEvents/News/default.htm

Related Content

St. Jude Medical, HeartMate 3 LVAS, MOMENTUM 3 IDE study results, AHA Scientific Sessions 2016
News | Ventricular Assist Devices (VAD)| December 08, 2016
St. Jude Medical Inc. announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late-breaking clinical trial...
Impella CP, Abiomed
News | Hemodynamic Support Devices| December 07, 2016
December 7, 2016 — Abiomed Inc. announced it has expanded its U.S.
Heartware HVAD, ventricular assist device, artificial heart, Medtronic
News | October 05, 2016
October 5, 2016 — Medtronic said two previously communicated global voluntary recalls related to the HeartWare Intern
CardioKinetix, Parachute device, Heart Failure device therapy

The CardioKinetix Parachute device implant shown deployed in the left ventricle of a heart failure patient. The device helps remodel the ventricle to improve the heart's ability to pump blood more efficiently. 

Feature | Heart Failure| September 29, 2016 | Abha Mishra
New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the
SynCardia, Chapter 11 reorganization, sale, Total Artificial Heart
News | Artificial Heart| September 13, 2016
August 29, 2016 — SynCardia Systems, manufacturer of the...
Carew Medical Wear, Rod Carew, undergarments, LVAD, HeartMate II, American Heart Association
News | Ventricular Assist Devices (VAD)| August 11, 2016
August 11, 2016 — Carew Medical Wear Inc., a custom medical outfit company specializing in...
SynCardia acquired, Versa Capital Management, chapter 11
News | Business| July 07, 2016
SynCardia Systems Inc. announced that it has entered into an asset purchase agreement (“APA”) with an affiliate of...
HeartWare, HVAD, batteries recall
News | Ventricular Assist Devices (VAD)| July 05, 2016
HeartWare Inc. announced a recall of the batteries used on the HeartWare Ventricular Assist Device (HVAD) because the...
St. Jude Medical, HeartMate 3 LVAS, LVAD, CardioStim-EHRA Europace Innovation Award 2016
News | Ventricular Assist Devices (VAD)| June 29, 2016
St. Jude Medical Inc. recently announced the company received an Innovation Award for its HeartMate 3 Left Ventricular...
Overlay Init